Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy
Bruckner, H.W.; Spigelman, M.
Mount Sinai Journal of Medicine new York 55(5): 390-394
1988
ISSN/ISBN: 0027-2507 PMID: 3265179 Document Number: 319336
Document emailed within 1 workday
Related Documents
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333
Cao, S.; Troutt, A.B.; Rustum, Y.M. 1998: Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer Cancer Research 58(8): 1695-1699
Yokomizo, H.; Yoshimatsu, K.; Hashimoto, M.; Ishibashi, K.; Umehara, A.; Yoshida, K.; Fujimoto, T.; Watanabe, K.; Ogawa, K. 2004: Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis Anticancer Research 24(2c): 1131-1134
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932
Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Yoshioka, T.; Wada, T.; Uchida, N.; Maki, H.; Yoshida, H.; Ide, N.; Kasai, H.; Hojo, K.; Shono, K.; Maekawa, R.; Yagi, S.; Hoffman, R.M.; Sugita, K. 1998: Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase Cancer Research 58(12): 2583-2587
Yee, L.K.; Allegra, C.J.; Steinberg, S.M.; Grem, J.L. 1992: Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a Journal of the National Cancer Institute 84(23): 1820-1825
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Fujiwara, K.; Kohno, I.; Tanaka, K.; Ogita, S.; Sasaki, Y.; Hirabayashi, K.; Yakushiji, M.; Tsunematsu, R.; Terashima, Y.; Taguchi, T.; Ohashi, Y.; Noda, K. 1999: Phase Ii dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group Anticancer Research 19(1b): 639-644
Allegra, C.J.; Egan, G.F.; Drake, J.C.; Steinberg, S.M.; Swain, S.M. 1988: The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin Advances in Experimental Medicine and Biology 244: 107-112
Aiba, K. 1988: Biochemical modulation of 5-fluorouracil by high-dose leucovorin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 392-408
Erlichman, C.; Wu, A. 1991: Effects of 5-fluorouracil and leucovorin in spheroids: a model for solid tumours Anticancer Research 11(2): 671-675
Hehr, T.; Adamek, H.E. 2002: Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 178(3): 164-166
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Fukunaga, T.; Aihara, N. 2003: Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(13): 2077-2081
Baur, M.; Schlappack, O.; Havelec, L.; Mader, R.; Marosi, C.; Scheithauer, W.; Dittrich, C. 1991: 5-Fluorouracil (5-FU)/leucovorin in comparison to other current chemotherapy protocols in metastasizing colorectal carcinoma Wiener Klinische Wochenschrift 103(11): 332-339
Zhang, H.-G.; Cai, R.-G.; Chen, S.-S.; Wu, F.; Chu, D.-T. 2007: 10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer Zhonghua Yi Xue Za Zhi 87(21): 1462-1464
Tokunaga, Y.; Ryo, J.; Kitaoka, A.; Yagi, T.; Tokuka, A.; Ohsumi, K. 1999: A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin Hepato-Gastroenterology 46(27): 1736-1739
Kobayashi, R.; Yoshimatsu, K.; Yokomizo, H.; Katsube, T.; Ogawa, K. 2007: Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity Anticancer Research 27(1b): 675-679